Bacterial Vaccines Market Size, Share & Trends Analysis Report By Type (Capsular Polysaccharide Vaccines, Toxoid Vaccines, Purified Protein Vaccines, Live Attenuated Bacterial Vaccines, Killed Bacterial Vaccines, Others) By Route of Administration (Oral, Parenteral, Other) By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) Based on Region, And Segment Forecasts, 2022 - 2028

  • Report ID: BMRC 1899 | Number of pages: 199 | Published Date: Mar 2022

    Published | Category: Vaccines | Delivery Timeline: 48 hrs

COVID-19
To know the impact of COVID-19 On Bacterial Vaccines Market Size, Share & Trends Analysis Report By Type (Capsular Polysaccharide Vaccines, Toxoid Vaccines, Purified Protein Vaccines, Live Attenuated Bacterial Vaccines, Killed Bacterial Vaccines, Others) By Route of Administration (Oral, Parenteral, Other) By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) Based on Region, And Segment Forecasts, 2022 - 2028 Market

Request Now
Market Size Forecast Scenarios (Optimistic, Baseline and Pessimistic) 2021-2027

Global Bacterial Vaccines Market is valued at USD 20.44 Billion in 2021 and expected to reach USD 34.80 Billion by 2028 with a CAGR of 7.9% over the forecast period.

Global Bacterial Vaccines Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2022-2028- Increasing prevalence of bacterial diseases, rising research activities in bacterial vaccines and growing government initiatives for prevention of diseases are major factors anticipated to drive the growth of the Global Bacterial Vaccines Market for the forecast period.

Scope of Global Bacterial Vaccines Market Report:-

Bacterial vaccines are suspension of killed or attenuated bacteria; used for injection into the body to produce active immunity to the same organism. Bacterial vaccines provide protection against particular bacteria that prevents bacterial infection by inducing antibodies. Bacterial vaccines contain gentle or eliminated type of bacteria that initiate the body's immune system. The vaccines against cholera, typhus, plague and Q fever contain entire killed bacteria. These vaccines are utilized uniquely to protect the people who are probably going to be exposed. Tuberculosis vaccine is a bacterial vaccine for the Tuberculosis. Many bacterial diseases can be prevented by using bacterial vaccines. The bacterial vaccines are used to prevent life threatening diseases and provide public health challenges of the 21st century.

The Covid-19 pandemic has also impacted the growth of global bacterial vaccines market. The vaccine development against Covid-19 was the most essential thing during initial stage of covid-19 pandemic. The bacterial vaccines such as DNA vaccines and clinical trials of various DNA vaccines for Covid-19 are carried out which has been positively impacted the global bacterial vaccines market.

Global Bacterial Vaccines Market Segmentation:-

The global bacterial vaccines market is segmented into on the basis of type, route of administration, distribution channel and region & country level. Based upon type, the global bacterial vaccines market is classified into capsular polysaccharide vaccines, purified protein vaccines, toxoid vaccines, live attenuated bacterial vaccines, killed bacterial vaccines and others. Based upon route of administration, the market is classified into oral, parenteral, and others. Based upon distribution channel, the global bacterial vaccine market is divided into retail pharmacies, hospital pharmacies and online pharmacies.

By Type:

  • Capsular Polysaccharide Vaccines
  • Toxoid Vaccines
  • Purified Protein Vaccines
  • Live Attenuated Bacterial Vaccines
  • Killed Bacterial Vaccines
  • Others

By Route of Administration:

  • Oral
  • Parenteral
  • Other

By Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

The regions covered in global bacterial vaccines market report are North America, Europe, Asia-Pacific, Latin America and Rest of the World. On the basis of country level, the market of global bacterial vaccines is subdivided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, India, Japan, South East Asia, Middle East Asia (UAE, Egypt, Saudi Arabia) GCC, Africa, etc.

bacterial vaccines market

Key Players of Global Bacterial Vaccines Market Report-

Some of the key players for global bacterial vaccines market are

  • Serum Institute of India
  • Merck
  • GlaxoSmithKline
  • Pfizer
  • Sanofi
  • Emergent BioDefense Operations Lansing
  • PaxVax
  • others.

Recent Developments

News- Plant and Bacteria Based Covid-19 Vaccines Can End the Pandemic, Said Study

On September 8th, 2021; University of California made new vaccines which can survive and hold their properties in heat. These new vaccines are under developmental stages and had shown high antibody reaction in mice. Bacteria utilized in vaccines have a lot of benefits over other accessible vaccines, for they can be delivered in huge scale. Indeed, even at incredibly high temperatures, the plant-based vaccines are amazingly steady, making their shipment interaction easier across all terrain. The vaccines are being bundled into polymer inserts as well as micro needle patches. Basically, the implants will be infused under one's skin and release the immunization throughout a month. The vaccine would be directed just a single time. Concerning the micro needle patches, those can be worn on one's arm without pain, the specialists guarantee.

FDA approved MenQuadfiTM, the Latest Innovation in Meningococcal (MenACWY) Vaccination

On April 24th, 2020; The U.S. Food and Drug Administration (FDA) approved MenQuadfiTM which is the conjugate immunization a Biologics License Application for MenQuadfiTM. Meningococcal Conjugate Vaccine for the anticipation of invasive meningococcal sickness in people 2 years old and more seasoned. MenQuadfiTM was intended to inspire and demonstrated a high immune response across every one of the four serogroups for multiple ages and was very much endured. MenQuadfiTM is planned to defend an extended age group.

Increasing Prevalence of Bacterial Diseases, Rising Research Activities in Bacterial Vaccines and Growing government Initiatives for Prevention of Diseases are Driving the Market Growth

One of the major factors driving the growth of the global bacterial vaccines market is increasing prevalence of bacterial diseases. Bacterial vaccines are developed to prevent potentially lethal childhood infections such as diphtheria and tetanus and many other diseases. There is a need of production of effective vaccines against these bacterial diseases which is increases the demand of bacterial vaccines. For instance; according to World Health Organization (WHO), in 2018, there are about 16,000 cases of diphtheria, globally. Thus, increasing number of bacterial diseases will increase the market of bacterial vaccines.

In addition, second factor supplementing the growth of bacterial vaccines is rising number of research activities in this field to develop more effective bacterial vaccines. Bacterial vaccines are current clinical interventions for infectious diseases are facing increasing challenges due to the ever-rising number of drug-resistant microbial infections, epidemic outbreaks of pathogenic bacteria. Thus, research and development in bacterial vaccines led development of new vaccines which is driving the market growth. For example, as per the news published on December 28th 2020, Serum Institute of India launched world's most affordable pneumococcal conjugate vaccine which is a bacterial vaccine in India.

Furthermore, growing government initiatives for prevention of diseases also drives the global bacterial vaccines market. Government carries different alertness programs, accessibility of vaccination programs, and home vaccination services for preventing infectious diseases such as bacterial diseases. Hence these programmes providing growth to the global bacterial vaccines market. However, high cost required for development of the bacterial vaccines may hamper growth of the global bacterial vaccines market. In spite of that, research and technological advancements in vaccines provide new opportunities in the growth of the global bacterial vaccines market.

North America is Expected to Dominate the Global Veterinary Clostridium Vaccines Market

The North America is expected to dominate the global bacterial vaccines market due to the high awareness regarding bacterial diseases, rising government initiatives regarding the preventive medicines and high research and development investment in this field. For example, huge efforts taken by the U.S., The Department of Health and Human Services (HHS) for confirming prevention medication for transmittable diseases is offered to all. Also, an FDA approval of vaccines also drives the market growth. For instance, as per the news published on April 24th, 2020, FDA approved MenQuadfiTM, the latest innovation in meningococcal (MenACWY) vaccination.

Europe is expected to be the second-largest market for bacterial vaccines due to government initiatives programs for warranting precautionary medicines governments to ensure preventive medicine is accessible for all the people for lethal infectious diseases.

Report Analysis Details
Historical data 2015 - 2020
Forecast Period 2021 - 2028
Market Size in 2021: USD 20.44 Billion 
Base year considered 2020
Forecast Period CAGR %:

7.9%

Market Size Expected in 2028: USD 34.80 Billion 
Tables, Charts & Figures: 175
Pages 200
Bacterial Vaccines Manufacturers Serum Institute of India, Merck, GlaxoSmithKline, Pfizer, Sanofi, Emergent BioDefense Operations Lansing, PaxVax, and others.
Segments Covered By Type, By Route of Administration, By Distribution Channel
Regional Analysis North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa

Key Benefits of Global Bacterial Vaccines Market Report-

  • Global Bacterial Vaccines Market report covers in-depth historical and forecast analysis.
  • Global Bacterial Vaccines Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
  • Global Bacterial Vaccines Market report helps to identify opportunities in marketplace.
  • Global Bacterial Vaccines Market report covers extensive analysis of emerging trends and competitive landscape.
On Special Requirement Bacterial Vaccines Market Report is also available for below Regions and Country:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Sweden
  • Netherland
  • Turkey
  • Switzerland
  • Belgium
  • Rest of Europe

Asia-Pacific

  • South Korea
  • Japan
  • China
  • India
  • Australia
  • Philippines
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Rest Of APAC

Latin America

  • Mexico
  • Colombia
  • Brazil
  • Argentina
  • Peru
  • Rest of South America

Middle East and Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest Of MEA

Top Related Report:


Frequently Asked Questions (FAQ) :
Global Bacterial Vaccine Market Size is Anticipated to garner $34.80 Billion by 2028 with a CAGR of 7.9% over the forecast period.
Global Bacterial Vaccines Market is valued at USD 20.44 Billion in 2021
Serum Institute of India, Merck, GlaxoSmithKline, Pfizer, Sanofi, Emergent BioDefense Operations Lansing, PaxVax, and others.
Increasing Prevalence of Bacterial Diseases, Rising Research Activities in Bacterial Vaccines and Growing government Initiatives for Prevention of Diseases are Driving the Market Growth
North America is Expected to Dominate the Global Veterinary Clostridium Vaccines Market



Interested in this report?

Bacterial Vaccines Market Size, Share, By Type, By Route of Administration

report cover

Request for Table of Content

Bacterial Vaccines Market Size, Share & Trends Analysis Report By Type (Capsular Polysaccharide Vaccines, Toxoid Vaccines, Purified Protein Vaccines, Live Attenuated Bacterial Vaccines, Killed Bacterial Vaccines, Others) By Route of Administration (Oral, Parenteral, Other) By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) Based on Region, And Segment Forecasts, 2022 - 2028

Note: For delivery of sample pages you must have a Domain Specific Email ID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc. are not accepted.
Brandessence market research actively tracks, monitors, and analyses key industry trends in real-time via B2B surveys in 60 + countries and territories.

    Pricing


Looking for Regional Reports?